112 related articles for article (PubMed ID: 1625405)
1. [A radiographic progression during and after initial chemotherapy for pulmonary tuberculosis].
Nakazono T
Kekkaku; 1992 Jun; 67(6):449-56. PubMed ID: 1625405
[TBL] [Abstract][Full Text] [Related]
2. [Retreatment of pulmonary tuberculosis--duration of chemotherapy].
Wada M; Seita A; Mori T; Ogata H; Sugie T; Sugita H
Kekkaku; 1993 Jul; 68(7):469-78. PubMed ID: 8361115
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
4. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
[TBL] [Abstract][Full Text] [Related]
5. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
6. [Nine month chemotherapy with INH and rifampicin for non-cavitary pulmonary tuberculosis].
Kino C; Sato M; Iwasaki T; Takase A; Kinoshita T; Yamaguchi T; Kinjo T; Odo A; Hara M; Hirata H
Kekkaku; 1991 Apr; 66(4):291-7. PubMed ID: 2051705
[TBL] [Abstract][Full Text] [Related]
7. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
Lancet; 1975 Jan; 1(7899):119-24. PubMed ID: 46047
[TBL] [Abstract][Full Text] [Related]
8. [Investigation on the treatment of infection due to Mycobacterium Kansasii].
Nakazono T; Sugie T; Ogata H; Mizutani S; Sugita H; Kino T; Wada M
Kekkaku; 1994 Oct; 69(10):587-92. PubMed ID: 7799569
[TBL] [Abstract][Full Text] [Related]
9. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
[TBL] [Abstract][Full Text] [Related]
10. Shortest possible acceptable, effective ambulatory chemotherapy in pulmonary tuberculosis: preliminary report I.
Mehrotra ML; Gautam KD; Chaube CK
Am Rev Respir Dis; 1981 Sep; 124(3):239-44. PubMed ID: 7283256
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy of pulmonary tuberculosis. Sputum culture conversion in 8 weeks in 84% of patients].
Nowak D; Radenbach D; Magnussen H
Dtsch Med Wochenschr; 1987 Sep; 112(36):1367-70. PubMed ID: 3622281
[TBL] [Abstract][Full Text] [Related]
12. A controlled trial of 3-month, 4-month, and 6-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 5 years. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council.
Am Rev Respir Dis; 1989 Apr; 139(4):871-6. PubMed ID: 2648911
[TBL] [Abstract][Full Text] [Related]
13. [Follow-up study of short course chemotherapy of pulmonary tuberculosis complicated with diabetes mellitus].
Kameda K; Kawabata S; Masuda N
Kekkaku; 1990 Dec; 65(12):791-803. PubMed ID: 2077255
[TBL] [Abstract][Full Text] [Related]
14. U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.
Long MW; Snider DE; Farer LS
Am Rev Respir Dis; 1979 Jun; 119(6):879-94. PubMed ID: 110184
[TBL] [Abstract][Full Text] [Related]
15. Smear- and culture-negative pulmonary tuberculosis: four-month short-course chemotherapy.
Dutt AK; Moers D; Stead WW
Am Rev Respir Dis; 1989 Apr; 139(4):867-70. PubMed ID: 2930066
[TBL] [Abstract][Full Text] [Related]
16. [Two cases of appearance of a new intrapulmonary lesion during antituberculous chemotherapy in tuberculous pleuritis].
Kobashi Y; Adachi M; Kimura M; Matsushima T
Kekkaku; 1991 Feb; 66(2):87-93. PubMed ID: 2023363
[TBL] [Abstract][Full Text] [Related]
17. A case series: initial outcome of persons with multidrug-resistant tuberculosis after treatment with the WHO standard retreatment regimen in Ho Chi Minh City, Vietnam.
Lan NTN ; Lademarco MF; Binkin NJ; Tung LB; Quy HT; Cĵ NV
Int J Tuberc Lung Dis; 2001 Jun; 5(6):575-8. PubMed ID: 11409587
[TBL] [Abstract][Full Text] [Related]
18. [Three cases of localized pleural tuberculosis which looked exacerbated during antituberculous chemotherapy].
Rikimaru T; Kawahara M; Ichikawa Y; Oizumi K; Nakamura M
Kekkaku; 1991 Feb; 66(2):101-7. PubMed ID: 2023359
[TBL] [Abstract][Full Text] [Related]
19. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
Ige OM; Bakare NA; Onadeko BO
Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
[TBL] [Abstract][Full Text] [Related]
20. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
